Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

12.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
154
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cancer Prevention02:59

Cancer Prevention

6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Luminescent Naphthalenediimide-Tröger's Base Covalent Organic Polymers for Selective, Sensitive, and Reversible Detection of Roxarsone in Aqueous Media.

Chemistry, an Asian journal·2026
Same author

Design and Evaluation of N-Aryl-4-amino-1,8-naphthalimide Fluorescent Sensors for Nitrofurazone Antibiotic Detection.

Chemistry, an Asian journal·2026
Same author

Boswellic Acid Derivatives: A Traditional and Multifunctional Therapeutic Agent for Infectious and Non-Infectious Diseases - A Comprehensive Review.

Chemistry & biodiversity·2026
Same author

Tunable Bioactive Glycine-Based Peptoids: Support-Free Scalable Synthesis of Sequence-Defined Oligomers/Dendrimers and Their SAR Studies.

ACS applied bio materials·2025
Same author

Real-Time In Situ Imaging of Aggregation-Induced Emission and Solvent-Guided Morphogenesis of a "V-Shaped" 4-Amino-1,8-Naphthalimide Tröger's Base Supramolecular Scaffold.

Small science·2025
Same author

Oncopacket: integration of cancer research data using GA4GH phenopackets.

Bioinformatics (Oxford, England)·2025

Related Experiment Video

Updated: Jun 14, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

57.6K

Zn(II)-Curcumin Complexes-Based Anticancer Agents.

Rajdeep Mondal1, Muthukumar Keerthana1, Nanjan Pandurangan2

  • 1Department of Chemistry, Indian Institute of Technology Palakkad, Palakkad, Kerala, 678557, India.

Chemmedchem
|September 3, 2024
PubMed
Summary

Researchers explored zinc(II)-curcumin complexes as novel anticancer metallodrugs. These complexes show improved bioavailability and targeted cancer cell delivery, offering a promising alternative to platinum(II)-derivatives.

Keywords:
Anticancer agentsBioimagingCurcuminMetallodrugsZn(II) complexes

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.0K
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

8.9K

Related Experiment Videos

Last Updated: Jun 14, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

57.6K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.0K
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

8.9K

Area of Science:

  • Medicinal Chemistry
  • Materials Science
  • Oncology

Background:

  • Platinum(II)-derivatives are widely used in cancer treatment but face challenges like poor solubility and bioavailability.
  • Bioactive ligands are being explored to enhance the efficacy and targeting of metallodrugs.
  • Curcumin, a natural compound, has demonstrated significant biological activities, including anticancer properties.

Purpose of the Study:

  • To synthesize and characterize zinc(II)-curcumin coordination complexes for cancer therapy.
  • To investigate the impact of functional groups, targeting ligands, and photo-active ligands on anticancer potential.
  • To review the current status and future prospects of curcumin-based metallodrugs.

Main Methods:

  • Synthesis of various zinc(II)-curcumin coordination complexes.
  • Structural elucidation of the synthesized complexes.
  • In vitro evaluation of anticancer properties and mechanism of action.

Main Results:

  • Successful synthesis of diverse Zn(II)-curcumin complexes with varying functionalization.
  • Demonstrated enhancement in anticancer activity and cancer cell targeting upon ligand modification.
  • Evidence of improved bioavailability and reduced toxicity compared to traditional agents.

Conclusions:

  • Zinc(II)-curcumin complexes represent a promising class of metallodrugs for cancer treatment.
  • Strategic modification of ligands can significantly optimize their therapeutic efficacy.
  • Further research into these complexes holds potential for developing next-generation anticancer therapies.